InvestorsHub Logo
icon url

$heff

07/22/15 8:29 AM

#89237 RE: $heff #89182

$XOMA.. Announces Results From Phase 3 EYEGUARD -B Study #FAIL http://t.co/wbsXysNpoa cc 8.30 ET
icon url

$heff

08/22/15 6:00 PM

#89812 RE: $heff #89182

$IMMU..$1.87..to report interim Ph.2 data with sacituzumab govitecan in patients with metastatic lung cancers on Sep 7th. http://t.co/GxbsifRRwd